Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome

Wei Wang,Jinyou Li,Siyuan Cui,Jiayu Li,Xianlong Ye,Zhe Wang,Tingting Zhang,Xuan Jiang,Yulin Kong,Xin Chen,Yong Q. Chen,Shenglong Zhu
DOI: https://doi.org/10.1126/sciadv.adj7813
IF: 13.6
2024-02-03
Science Advances
Abstract:Metabolic syndrome (MetS) is closely associated with an increased risk of dementia and cognitive impairment, and a complex interaction of genetic and environmental dietary factors may be implicated. Free fatty acid receptor 4 (Ffar4) may bridge the genetic and dietary aspects of MetS development. However, the role of Ffar4 in MetS-related cognitive dysfunction is unclear. In this study, we found that Ffar4 expression is down-regulated in MetS mice and MetS patients with cognitive impairment. Conventional and microglial conditional knockout of Ffar4 exacerbated high-fat diet (HFD)–induced cognitive dysfunction and anxiety, whereas microglial Ffar4 overexpression improved HFD-induced cognitive dysfunction and anxiety. Mechanistically, we found that microglial Ffar4 regulated microglial activation through type I interferon signaling. Microglial depletion and NF-κB inhibition partially reversed cognitive dysfunction and anxiety in microglia-specific Ffar4 knockout MetS mice. Together, these findings uncover a previously unappreciated role of Ffar4 in negatively regulating the NF-κB–IFN-β signaling and provide an attractive therapeutic target for delaying MetS-associated cognitive decline.
multidisciplinary sciences
What problem does this paper attempt to address?